Johnson Financial Group Inc (Wisconsin)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-33
Closed -$1.68K – 897
2026
Q1
$1.68K Hold
33
– – ﹤0.01% 808
2025
Q4
$974 Sell
33
-182
-85% -$4.95K ﹤0.01% 890
2025
Q3
$5.55K Buy
+215
New +$6K ﹤0.01% 837
2024
Q2
– Sell
-20
Closed -$2.13K – 912
2024
Q1
$2.13K Buy
+20
New +$2.02K ﹤0.01% 630
2022
Q3
– Sell
-126
Closed -$18K – 728
2022
Q2
$18K Hold
126
– – ﹤0.01% 481
2022
Q1
$22K Hold
126
– – ﹤0.01% 525
2021
Q4
$32K Buy
+126
New +$36.8K ﹤0.01% 514
2020
Q3
– Sell
-120
Closed -$8K – 459
2020
Q2
$8K Buy
+120
New +$6.57K ﹤0.01% 380

Other funds holding MRNA

Johnson Financial Group Inc (Wisconsin)'s MRNA Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Moderna (MRNA) in Q2 2026, closing a stake of 33 shares — an estimated $1.68K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in MRNA in Q2 2020 and held it in 8 quarters. The position peaked at $32K in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 33 Moderna shares in Q2 2026, an estimated $1.68K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Moderna in Q2 2020 and held it in 8 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Moderna position peaked at $32K in Q4 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.